8OQ5 image
Entry Detail
PDB ID:
8OQ5
EMDB ID:
Keywords:
Title:
AApoAII amyloid fibril Morphology I (ex vivo)
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2023-04-11
Release Date:
2024-02-21
Method Details:
Experimental Method:
Resolution:
2.40 Å
Aggregation State:
FILAMENT
Reconstruction Method:
HELICAL
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Apolipoprotein A-II
Chain IDs:A, B, C, D, E, F, G, H, I, J (auth: L), K (auth: M), L (auth: N)
Chain Length:78
Number of Molecules:12
Biological Source:Mus musculus
Ligand Molecules
Primary Citation
Insights into the Structural Basis of Amyloid Resistance Provided by Cryo-EM Structures of AApoAII Amyloid Fibrils.
J.Mol.Biol. 436 168441 168441 (2024)
PMID: 38199491 DOI: 10.1016/j.jmb.2024.168441

Abstact

Amyloid resistance is the inability or the reduced susceptibility of an organism to develop amyloidosis. In this study we have analysed the molecular basis of the resistance to systemic AApoAII amyloidosis, which arises from the formation of amyloid fibrils from apolipoprotein A-II (ApoA-II). The disease affects humans and animals, including SAMR1C mice that express the C allele of ApoA-II protein, whereas other mouse strains are resistant to development of amyloidosis due to the expression of other ApoA-II alleles, such as ApoA-IIF. Using cryo-electron microscopy, molecular dynamics simulations and other methods, we have determined the structures of pathogenic AApoAII amyloid fibrils from SAMR1C mice and analysed the structural effects of ApoA-IIF-specific mutational changes. Our data show that these changes render ApoA-IIF incompatible with the specific fibril morphologies, with which ApoA-II protein can become pathogenic in vivo.

Legend

Protein

Chemical

Disease

Primary Citation of related structures